Development of breast cancer stem-like cells are associated with expression of low levels of CD24, high levels of CD44, aldehyde dehydrogenase, and the IL8-binding chemokine receptor CXCR1 [137–140]. This evidence concerns the gene CD44 and breast carcinoma.